Please assess the completion status of the following clinical trial:

Trial Title: Autologous Mesenchymal Stromal Cell Therapy in Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* EF \< 45 %~* NYHA 2 - 3~Exclusion Criteria:~* Acute coronary syndrome within last 6 weeks.~* Pregnancy~* FEV1 \<1.0~* Cancer~* Any severe disease which could interfere with the treatment or the outcome

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): The number of mesenchymal stromal cells reached after two culture expansion passages.
- 2 (Type: PLACEBO_COMPARATOR): Saline

Based on this trial design, predict the completion outcome and termination type (if applicable).